These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 5712102

  • 1. [Considerations on the treatment of edemato-ascitic syndromes of hepatic origin. Apropos of the utilization of an antialdosterone].
    Levrat R, Savoye B, Imbert D.
    J Med Lyon; 1968 Dec 05; 49(154):1887-99. PubMed ID: 5712102
    [No Abstract] [Full Text] [Related]

  • 2. [Pathogenesis and therapy of ascites in hepatic cirrhosis].
    Persico L.
    Policlinico Prat; 1971 Feb 01; 78(3):100-9. PubMed ID: 5572866
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of the edemato-ascitic syndrome with an injectable aldosterone antagonist: 8109 CB].
    Dubarry JJ, Bancons J, Quinton A.
    Bord Med; 1971 Dec 01; 4(12):3751-7. PubMed ID: 5146181
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of the edemato-ascitic syndrome in cirrhotics, role of amiloride (MK870)].
    Quinton A, Bancons J, Dubarry JJ.
    Bord Med; 1972 Oct 01; 5(16):2141-9. PubMed ID: 4640793
    [No Abstract] [Full Text] [Related]

  • 5. [Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment].
    Torre A, Terra C, Guevara M, Ginès P.
    Gastroenterol Hepatol; 2004 Feb 01; 27 Suppl 1():8-14. PubMed ID: 15195529
    [No Abstract] [Full Text] [Related]

  • 6. [Refractory hepatic cirrosis and the ineffectiveness of diuretics in ascites and edema].
    Inoue J, Mori Y, Kawamura T.
    Naika; 1969 Nov 01; 24(5):834-9. PubMed ID: 4902224
    [No Abstract] [Full Text] [Related]

  • 7. [Modern diuretics in the treatment of ascites caused by hepatic cirrhosis].
    Buligescu L, Candiori R.
    Med Interna (Bucur); 1970 May 01; 22(5):573-92. PubMed ID: 5426383
    [No Abstract] [Full Text] [Related]

  • 8. [Current treatment of the edematous ascitic syndrome in alcoholic liver cirrhosis].
    Savoye B, Gayet C.
    J Med Lyon; 1969 Dec 20; 50(177):1831-41. PubMed ID: 5374238
    [No Abstract] [Full Text] [Related]

  • 9. The management of ascites and hyponatremia in cirrhosis.
    Ginès P, Cárdenas A.
    Semin Liver Dis; 2008 Feb 20; 28(1):43-58. PubMed ID: 18293276
    [Abstract] [Full Text] [Related]

  • 10. [Water and sodium metabolism in non-compensated hepatic cirrhosis: therapeutic indications according to the Arroyo classification].
    Cavatorta F, Queirolo C, Brignole M, Zangani F.
    Clin Ter; 1980 Jan 31; 92(2):143-53. PubMed ID: 7389274
    [No Abstract] [Full Text] [Related]

  • 11. [Therapeutic possibilities and risks in hepatic cirrhosis with water-electrolyte metabolism disorders].
    Schwartz M, Fodor O.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975 Jan 31; 27(3):219-25. PubMed ID: 770
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of ascites in liver diseases].
    Gerbes AL, Paumgartner G.
    Dtsch Med Wochenschr; 1994 Nov 11; 119(45):1549-54. PubMed ID: 7956790
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of diuretic treatment on body composition in liver cirrhosis: radioisotope dilution study of the effect of amiloride (MK-870)].
    Quoidbach A, Busset R, Jenny M.
    Praxis; 1969 Sep 23; 58(38):1197-201. PubMed ID: 4910991
    [No Abstract] [Full Text] [Related]

  • 14. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS, Park GT, Kim YH, Shim SG, Kim JB, Lee OY, Choi HS, Hahm JS, Lee MH.
    Taehan Kan Hakhoe Chi; 2003 Dec 23; 9(4):324-31. PubMed ID: 14695699
    [Abstract] [Full Text] [Related]

  • 15. [Contribution to the study of the treatment of the ascitic syndrome of cirrhosis by the combination of spironolactone and sulfonamide diuretic. Initial therapy and supportive therapy. Apropos of 55 cases].
    Fraisse H, Perret M, Etaix JP.
    J Med Lyon; 1967 Feb 05; 48(114):173-83. PubMed ID: 5600100
    [No Abstract] [Full Text] [Related]

  • 16. Bumetanide in the treatment of hepatic ascites.
    Ring-Larsen H.
    Postgrad Med J; 1975 Feb 05; 51 Suppl 6():77-81. PubMed ID: 1105536
    [No Abstract] [Full Text] [Related]

  • 17. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
    Lenaerts A, Codden T, Henry JP, Van Cauter J, Meunier JC, Ligny G.
    Gastroenterol Clin Biol; 2001 Mar 05; 25(3):268-72. PubMed ID: 11395674
    [Abstract] [Full Text] [Related]

  • 18. Clinical experience with metolazone--a new diuretic--in cases of edema and ascites due to hepatic cirrhosis, C.C.F., and malnutrition.
    Sheth UK, Mehta JM, Paul T, Nair S, Sanghvi B.
    J Postgrad Med; 1977 Oct 05; 23(4):147-55. PubMed ID: 615260
    [No Abstract] [Full Text] [Related]

  • 19. [Use of diuretics from the functional viewpoint. 7. Treatment of edema. (2). Treatment of edema and ascites caused by heart failure or liver cirrhosis].
    Furukawa T.
    Saishin Igaku; 1965 Jul 05; 20(7):1743-58. PubMed ID: 5884753
    [No Abstract] [Full Text] [Related]

  • 20. Management of ascites in patients with chronic liver disease.
    Aiza I, Perez GO, Schiff ER.
    Am J Gastroenterol; 1994 Nov 05; 89(11):1949-56. PubMed ID: 7942716
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.